A study of over 1000 people aged 55 years and over found an inverse correlation between serum total and bioavailable testosterone and the amount of aortic atherosclerosis in men, as assessed by radiological methods (Hak et al 2002). This results in reduced testosterone levels, which increase the action of lipoprotein lipase and increase fat mass, thus increasing aromatisation of testosterone and completing the cycle. Baseline testosterone levels were in the low-normal range and patients received a relatively small dose of 100 mg intramuscular testosterone every three weeks. Body mass index was within the normal range in this population and there was no change in waist-hip ratio or weight during testosterone treatment. Other significant changes during testosterone treatment in this trial were reduced total cholesterol, waist circumference and waist-hip ratio. A series of studies investigated the effects of testosterone or dihydrotestosterone given for 6 weeks or 3 months to middle aged, non-diabetic obese men (Marin, Holmang et al 1992; Marin, Krotkiewski et al 1992; Marin et al 1993). It suggests that the ability to cope with stress, adapt to change, and maintain a positive outlook can have a profound impact on overall health and well-being. Moderation is key, and avoiding excessive alcohol consumption can significantly reduce the risk of numerous health problems. Men are generally more likely to engage in heavy drinking than women, which can contribute to a shorter lifespan. While smoking rates have declined in many countries, the legacy of decades of higher tobacco use among men continues to impact their health outcomes. Smoking is a major risk factor for numerous diseases, including cancer, heart disease, and respiratory problems. This earlier onset and greater severity of heart disease in men may be attributed to a combination of factors, including genetic predisposition, lifestyle choices, and hormonal differences. This historical legacy of hazardous occupations may still be contributing to the longevity gap between men and women. Further controversy surrounds setting a lower limit of normal testosterone, the limitations of the commonly available total testosterone result in assessing some patients and the unavailability of reliable measures of bioavailable or free testosterone for general clinical use. He performed a common blood test called "total testosterone," which measures all of the body's testosterone levels, but doesn't account for which proteins are biologically active. Kaeberlein saw a doctor and got his testosterone levels tested that year, but it took more testing — and some trial-and-error with medications and supplements — for him to figure out a treatment plan that works for him. Testosterone provides the foundation for Hone’s testosterone replacement therapy plans, used to treat low testosterone levels and boost energy, strength, and libido. If you’ve optimized your lifestyle but your testosterone levels are still low, Norton says it may be time for medical intervention. Lower body, multi-joint movements are especially effective at boosting testosterone levels. He optimizes his testosterone levels with diet and exercise. Everyone thinks that testosterone is causing prostate cancer, when what we’re seeing is the cancers that grow without the hormone are worse," Attia said. Controversy in defining the clinical syndrome continues due to the high prevalence of hypogonadal symptoms in the aging male population and the non-specific nature of these symptoms. "If men are looking for increased muscle mass and strength, testosterone alone isn't going to do it," he said. Kaeberlein ordered a "free testosterone" test, which measures more specific hormones connected to testosterone and sperm production, in addition to measuring his total testosterone. Sarcopenia—the age-related loss of muscle mass and strength—is a major factor in frailty, falls, and loss of independence in older adults. Some of these studies specifically examine these changes in older men (Tenover 1992; Morley et al 1993; Urban et al 1995; Sih et al 1997; Snyder et al 1999; Kenny et al 2001; Ferrando et al 2002; Steidle et al 2003; Page et al 2005). There were sequential decreases in fat mass and increases in fat free mass with each increase of testosterone dose. A given testosterone dose produced higher serum concentrations of testosterone in the older age group (Bhasin et al 2005). Initially the experiments involved men aged 18–35 years (Bhasin et al 2001) but subsequently the study was repeated with a similar protocol in men aged 60–75 years (Bhasin et al 2005).
